Cargando…

Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation

Regulatory T cells (Tregs) play an important role in immunoregulation and have been shown in animal models to promote transplantation tolerance and curb autoimmunity following their adoptive transfer. The safety and potential therapeutic efficacy of these cells has already been reported in Phase I t...

Descripción completa

Detalles Bibliográficos
Autores principales: Safinia, Niloufar, Scotta, Cristiano, Vaikunthanathan, Trishan, Lechler, Robert I., Lombardi, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553385/
https://www.ncbi.nlm.nih.gov/pubmed/26379673
http://dx.doi.org/10.3389/fimmu.2015.00438
_version_ 1782387879743324160
author Safinia, Niloufar
Scotta, Cristiano
Vaikunthanathan, Trishan
Lechler, Robert I.
Lombardi, Giovanna
author_facet Safinia, Niloufar
Scotta, Cristiano
Vaikunthanathan, Trishan
Lechler, Robert I.
Lombardi, Giovanna
author_sort Safinia, Niloufar
collection PubMed
description Regulatory T cells (Tregs) play an important role in immunoregulation and have been shown in animal models to promote transplantation tolerance and curb autoimmunity following their adoptive transfer. The safety and potential therapeutic efficacy of these cells has already been reported in Phase I trials of bone-marrow transplantation and type I diabetes, the success of which has motivated the broadened application of these cells in solid-organ transplantation. Despite major advances in the clinical translation of these cells, there are still key questions to be addressed to ensure that Tregs attest their reputation as ideal candidates for tolerance induction. In this review, we will discuss the unique traits of Tregs that have attracted such fame in the arena of tolerance induction. We will outline the protocols used for their ex vivo expansion and discuss the future directions of Treg cell therapy. In this regard, we will review the concept of Treg heterogeneity, the desire to isolate and expand a functionally superior Treg population and report on the effect of differing culture conditions. The relevance of Treg migratory capacity will also be discussed together with methods of in vivo visualization of the infused cells. Moreover, we will highlight key advances in the identification and expansion of antigen-specific Tregs and discuss their significance for cell therapy application. We will also summarize the clinical parameters that are of importance, alongside cell manufacture, from the choice of immunosuppression regimens to the number of injections in order to direct the success of future efficacy trials of Treg cell therapy. Years of research in the field of tolerance have seen an accumulation of knowledge and expertise in the field of Treg biology. This perpetual progression has been the driving force behind the many successes to date and has put us now within touching distance of our ultimate success, immunological tolerance.
format Online
Article
Text
id pubmed-4553385
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-45533852015-09-14 Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation Safinia, Niloufar Scotta, Cristiano Vaikunthanathan, Trishan Lechler, Robert I. Lombardi, Giovanna Front Immunol Immunology Regulatory T cells (Tregs) play an important role in immunoregulation and have been shown in animal models to promote transplantation tolerance and curb autoimmunity following their adoptive transfer. The safety and potential therapeutic efficacy of these cells has already been reported in Phase I trials of bone-marrow transplantation and type I diabetes, the success of which has motivated the broadened application of these cells in solid-organ transplantation. Despite major advances in the clinical translation of these cells, there are still key questions to be addressed to ensure that Tregs attest their reputation as ideal candidates for tolerance induction. In this review, we will discuss the unique traits of Tregs that have attracted such fame in the arena of tolerance induction. We will outline the protocols used for their ex vivo expansion and discuss the future directions of Treg cell therapy. In this regard, we will review the concept of Treg heterogeneity, the desire to isolate and expand a functionally superior Treg population and report on the effect of differing culture conditions. The relevance of Treg migratory capacity will also be discussed together with methods of in vivo visualization of the infused cells. Moreover, we will highlight key advances in the identification and expansion of antigen-specific Tregs and discuss their significance for cell therapy application. We will also summarize the clinical parameters that are of importance, alongside cell manufacture, from the choice of immunosuppression regimens to the number of injections in order to direct the success of future efficacy trials of Treg cell therapy. Years of research in the field of tolerance have seen an accumulation of knowledge and expertise in the field of Treg biology. This perpetual progression has been the driving force behind the many successes to date and has put us now within touching distance of our ultimate success, immunological tolerance. Frontiers Media S.A. 2015-08-31 /pmc/articles/PMC4553385/ /pubmed/26379673 http://dx.doi.org/10.3389/fimmu.2015.00438 Text en Copyright © 2015 Safinia, Scotta, Vaikunthanathan, Lechler and Lombardi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Safinia, Niloufar
Scotta, Cristiano
Vaikunthanathan, Trishan
Lechler, Robert I.
Lombardi, Giovanna
Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
title Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
title_full Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
title_fullStr Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
title_full_unstemmed Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
title_short Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
title_sort regulatory t cells: serious contenders in the promise for immunological tolerance in transplantation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553385/
https://www.ncbi.nlm.nih.gov/pubmed/26379673
http://dx.doi.org/10.3389/fimmu.2015.00438
work_keys_str_mv AT safinianiloufar regulatorytcellsseriouscontendersinthepromiseforimmunologicaltoleranceintransplantation
AT scottacristiano regulatorytcellsseriouscontendersinthepromiseforimmunologicaltoleranceintransplantation
AT vaikunthanathantrishan regulatorytcellsseriouscontendersinthepromiseforimmunologicaltoleranceintransplantation
AT lechlerroberti regulatorytcellsseriouscontendersinthepromiseforimmunologicaltoleranceintransplantation
AT lombardigiovanna regulatorytcellsseriouscontendersinthepromiseforimmunologicaltoleranceintransplantation